This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Radosavljevic, M.
Right arrow Articles by Herbrecht, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Radosavljevic, M.
Right arrow Articles by Herbrecht, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 1999, p. 475-477, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Candida catenulata Fungemia in a Cancer Patient

Mirjana Radosavljevic,1 Hélène Koenig,1 Valérie Letscher-Bru,1 Jocelyn Waller,1 Fréderic Maloisel,2 Bruno Lioure,2 and Raoul Herbrecht2,*

Institut de Parasitologie et de Pathologie Tropicale, Faculté de Médecine, 67000 Strasbourg,1 and Service d'Onco-Hématologie, Hôpital de Hautepierre, 67098 Strasbourg,2 France

Received 17 August 1998/Returned for modification 21 September 1998/Accepted 28 October 1998

We report the first case of fungemia due to Candida catenulata, a contaminant of dairy products. C. catenulata was isolated from three blood cultures of a patient with gastric cancer. The patient failed to respond to fluconazole but recovered after treatment was switched to amphotericin B. In vitro, C. catenulata was susceptible to amphotericin B and itraconazole and was also susceptible to fluconazole in dose-dependent manner. The likely portal of entry was the digestive tract, as the patient often ate cheese and had multiple gastric ulcerations.

* Corresponding author. Mailing address: Service d'Onco-Hématologie, Hôpital de Hautepierre, Avenue Molière, 67098 Strasbourg, France. Phone: 33 388 12 76 88. Fax: 33 388 12 76 81. E-mail: raoul.herbrecht{at}chru-strasbourg.fr.

Journal of Clinical Microbiology, February 1999, p. 475-477, Vol. 37, No. 2
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Alcoba-Florez, J., Mendez-Alvarez, S., Cano, J., Guarro, J., Perez-Roth, E., del Pilar Arevalo, M. (2005). Phenotypic and Molecular Characterization of Candida nivariensis sp. nov., a Possible New Opportunistic Fungus. J. Clin. Microbiol. 43: 4107-4111 [Abstract] [Full Text]  
  • Chandrasekar, K., Shyla, J. H., Malathi, R. (2000). Can Antitumor Platinum Compounds Be Effective against Candida albicans?--- A Screening Assay Using Disk Diffusion Method. J. Clin. Microbiol. 38: 3905-3905 [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»